Last month a team of doctors and scientists made the case to regulators at the Food and Drug Administration (FDA) to consider approving anti-aging drugs as a new pharmaceutical class. Such a designation would treat aging as disease rather than a natural process, potentially opening the door to government funding for anti-aging drug trials.
from Gizmodo http://ift.tt/1KxoFFE
via Gizmodo
Nincsenek megjegyzések:
Megjegyzés küldése